The country accounts for approximately 32% of the Asia-Pacific market in 2024. India’s coronary drug-eluting stent market is ...

Based on the continual rise of coronary artery diseases in India, data-analytics firm GlobalData has projected a four per ...

Inflammation of the arteries is a primary precursor and driver of cardiovascular disease—the No. 1 killer of people in the ...

Former CM of Maharashtra Uddhav Thackeray has been admitted to a Mumbai hospital for a check-up. The chief of Shiv Sena (UBT) ...

Summary: The use of balloon angioplasty with or without coronary artery stenting is limited by the phenomenon of in-stent restenosis (ISR). Until very recently, most efforts to overcome ISR had ...

InspireMD (Nasdaq:NSPR) announced today that the FDA granted investigational device exemption (IDE) for its CGuard Prime ...

Stitt, 51, underwent intravenous surgery on Friday to repair a blockage in a main artery of his heart. Abegail Cave, the ...

Smits and a distinguished team of international researchers, the trial compares the performance of SMT's biodegradable-polymer sirolimus-eluting Supraflex Cruz stent with the biodegradable-polymer ...

SMT's Supraflex Cruz drug-eluting stent has been approved by Australia's Therapeutic Goods Administration. This approval ...

Contego Medical announced FDA premarket approval of the company’s Neuroguard IEP system. The three-in-one carotid stentin ...

Sahajanand Medical Technologies successfully completed enrollment of 1,550 patients for the Multivessel TALENT trial, ...